戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                    The primary objective was safety evaluation.
2 ys after each vaccination were collected for safety evaluation.
3 for 6 months after vaccination comprised the safety evaluation.
4 o progression (TTP), response rate (RR), and safety evaluation.
5  scientific data would aid the robustness of safety evaluation.
6  received different doses of BNP116.I-1c for safety evaluation.
7 h most publications are focused on) for drug safety evaluation.
8 llow-up of patients is ongoing for long-term safety evaluation.
9 uation and blood analysis were performed for safety evaluation.
10 uced no clinically meaningful signals in the safety evaluations.
11 16.2 hours) precludes definitive efficacy or safety evaluations.
12  lead in-vitro strategy for drug testing and safety evaluations.
13 cal and clinical laboratory assessments, and safety evaluations.
14 wide applications in disease detection, food safety evaluation and environmental assessment.
15 tion is a critical component for preclinical safety evaluation, and we demonstrate here that a combin
16 tool for genotoxicity screening for chemical safety evaluation, as well as for environmental and occu
17  the clinic for predose blood collection and safety evaluation at baseline (days 3, 7, and 14 and aga
18 onal design of live virus vaccines and their safety evaluation; attenuation is mediated through enhan
19 te intakes for nutrition monitoring and food safety evaluations, but available intake data are seriou
20 to additional contexts, particularly product safety evaluation, comparative effectiveness research, a
21 dies with vigorous attention to methodology, safety evaluation, cost analysis and clinically meaningf
22  utilised in formulating spray schedules and safety evaluation for chromafenozide insecticide in stra
23 nnel has now become an important part of the safety evaluation in the process of drug discovery.
24 s well as myocardial degeneration in in vivo safety evaluations in rats.
25                                              Safety evaluations included monitoring of adverse events
26                                              Safety evaluations included solicited reactogenicity and
27 ronil is not a metabolite in mammals, so the safety evaluations must take into account not only the p
28                                 With ongoing safety evaluations, natalizumab is being reevaluated by
29 his randomized noncomparative design allowed safety evaluation of 2 interventions concurrently in the
30                                A preliminary safety evaluation of ACC2 inhibitor 1-(S) revealed serio
31                            Consequently, the safety evaluation of Bt rice on BPH and PWS should be co
32 rformed followed by a long-term efficacy and safety evaluation of dual-site right atrial pacing in pa
33                                (Efficacy and Safety Evaluation of SAR236553 [REGN727] in Patients Wit
34 ology development in toxicology and clinical safety evaluation, particularly in vitro approaches, tha
35 ovides a starting point for planning vaccine safety evaluations using claims-based data sources.
36                             Duration of drug safety evaluation was 1 year or less for 26 of 34 trials
37                                              Safety evaluation was based on clinical laboratory and a
38                                   A thorough safety evaluation was conducted.
39                                          The safety evaluation was not masked for potentially deploye
40                                              Safety evaluations were performed at each visit and exer
41                                              Safety evaluations were performed on all patients.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。